ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML

This study is ongoing, but not recruiting participants.
Study NCT00067028.   Last updated on November 19, 2008.   Information provided by M.D. Anderson Cancer Center
Please refer to this study by its ClinicalTrials.gov identifier: NCT00067028


Locations
United States, Texas
M.D. Anderson Cancer Center    
      Houston, Texas, United States, 77030

Sponsors and Collaborators
M.D. Anderson Cancer Center
Genzyme

Investigators
Principal Investigator:     Stefan H Faderl, MD     M.D. Anderson Cancer Center    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers